ILIA TIKHOMIROV
Former Chief Executive Officer, 35Pharma
Ilia is a serial biotech entrepreneur and executive who has helped build multiple companies that achieved successful M&A exits. Most recently, Ilia helped found 35Pharma, a clinical stage pulmonary hypertension company that was acquired by GSK.
Prior to 35Pharma, he helped found Forbius, a clinical stage fibrosis and immunooncology company which was acquired by Bristol Myers Squibb. Prior to that, Ilia held various roles at YM Biosciences until its acquisition by Gilead.
Ilia holds an MBA and a Master of Biotechnology from the University of Toronto.
